Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03420651 · ClinicalTrials.gov registry record · NA
Peak Expiratory Flow Rate for Emergency Department Management of Acute Asthma Exacerbation
A NA study, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
NCT03420651 is a NA study that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 188 participants.
The verdict
NCT03420651, a NA study, has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
Study Summary
Patients presenting to the emergency department with acute asthma exacerbation will be assigned to peak-expiratory flow rate (PEFR) guided management and non-PEFR guided management.
Interventions
- OTHER Peak Expiratory Flow Rate (PEFR)
- OTHER Standard Clinical Judgement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2018-01-19 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03420651
The ClinicalTrials.gov registry entry for NCT03420651 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peak Expiratory Flow Rate (PEFR) is the first listed.
NCT03420651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03420651 about?
NCT03420651 is a clinical study titled "Peak Expiratory Flow Rate for Emergency Department Management of Acute Asthma Exacerbation". Patients presenting to the emergency department with acute asthma exacerbation will be assigned to peak-expiratory flow rate (PEFR) guided management and non-PEFR guided management.
What is the current status of trial NCT03420651?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2018-01-19. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT03420651?
The interventions under investigation include: Peak Expiratory Flow Rate (PEFR) (OTHER), Standard Clinical Judgement (OTHER).
Who is sponsoring clinical trial NCT03420651?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.